| scholarly article | Q13442814 |
| P2093 | author name string | Jin-Yan Wang | |
| Jian-You Guo | |||
| Rui-Rui Zhang | |||
| Wen-Cai Zhang | |||
| P2860 | cites work | Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses | Q28510086 |
| Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. | Q33229895 | ||
| Neuroimaging study of placebo analgesia in humans | Q33506955 | ||
| Synapse regression in depression: the role of 5-HT receptors in modulating NMDA receptor function and synaptic plasticity | Q33543949 | ||
| Endothelin-A receptor antagonism attenuates carcinoma-induced pain through opioids in mice | Q33936628 | ||
| Placebo-induced changes in FMRI in the anticipation and experience of pain | Q33976101 | ||
| How the number of learning trials affects placebo and nocebo responses | Q34204013 | ||
| The mechanism of placebo analgesia | Q34332029 | ||
| The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia | Q34394877 | ||
| Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. | Q34445458 | ||
| Neurobiological mechanisms of the placebo effect. | Q34466524 | ||
| Frontocingulate dysfunction in depression: toward biomarkers of treatment response | Q34565649 | ||
| A comprehensive review of the placebo effect: recent advances and current thought | Q34634630 | ||
| Opioid-mediated placebo responses boost pain endurance and physical performance: is it doping in sport competitions? | Q34708636 | ||
| Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses | Q34746177 | ||
| Placebo effects on human mu-opioid activity during pain | Q35846183 | ||
| Rostral anterior cingulate cortex volume correlates with depressed mood in normal healthy children | Q36492219 | ||
| Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats | Q36932895 | ||
| The dynamic mechanisms of placebo induced analgesia: Evidence of sustained and transient regional involvement | Q37295567 | ||
| Placebo analgesia and beyond: a melting pot of concepts and ideas for neuroscience | Q37902842 | ||
| Molecular biology of the opioid receptors: structures, functions and distributions. | Q38291878 | ||
| Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene | Q41157124 | ||
| The neurobiology of placebo analgesia: from endogenous opioids to cholecystokinin | Q41499548 | ||
| Placebo and opioid analgesia-- imaging a shared neuronal network | Q42162385 | ||
| Activation of the opioidergic descending pain control system underlies placebo analgesia. | Q43285483 | ||
| Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay | Q44335990 | ||
| Blockade of endogenous opioid neurotransmission enhances acquisition of conditioned fear in humans. | Q44338870 | ||
| Dissection of placebo analgesia in mice: the conditions for activation of opioid and non-opioid systems | Q44342375 | ||
| Regulation of Human Affective Responses by Anterior Cingulate and Limbic µ-Opioid Neurotransmission | Q44343422 | ||
| Deficit in attachment behavior in mice lacking the mu-opioid receptor gene | Q44345862 | ||
| Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors | Q44348000 | ||
| Placebo analgesia affects the behavioral despair tests and hormonal secretions in mice | Q45832918 | ||
| Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. | Q47229354 | ||
| Brain mechanisms of expectation associated with insula and amygdala response to aversive taste: implications for placebo. | Q48653546 | ||
| Placebo analgesia induced by social observational learning. | Q50600120 | ||
| Words without mind. | Q51427186 | ||
| Placebo and naloxone can alter post-surgical pain by separate mechanisms. | Q51850673 | ||
| P433 | issue | 4 | |
| P921 | main subject | placebo | Q269829 |
| opioid | Q427523 | ||
| P304 | page(s) | 849-856 | |
| P577 | publication date | 2012-07-25 | |
| P1433 | published in | The International Journal of Neuropsychopharmacology | Q7742309 |
| P1476 | title | The opioid placebo analgesia is mediated exclusively through μ-opioid receptor in rat. | |
| P478 | volume | 16 |
| Q36316617 | A new animal model of placebo analgesia: involvement of the dopaminergic system in reward learning |
| Q90304129 | Challenges of differential placebo effects in contemporary medicine: The example of brain stimulation |
| Q27007091 | Cognitive and emotional control of pain and its disruption in chronic pain |
| Q92927502 | In search of a rodent model of placebo analgesia in chronic orofacial neuropathic pain |
| Q43075563 | Mechanisms of placebo analgesia: A dual-process model informed by insights from cross-species comparisons |
| Q47912833 | Pain and the context |
| Q55115546 | Placebo Analgesia in Rodents: Current and Future Research. |
| Q37655894 | Placebo and the new physiology of the doctor-patient relationship |
| Q37719487 | Relieving pain using dose-extending placebos: a scoping review |
Search more.